These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 37344)

  • 1. Selective inhibition of rat and human cardiac guanylate cyclase in vitro by doxorubicin (adriamycin): possible link to anthracycline cardiotoxicity.
    Levey GS; Levey BA; Ruiz E; Lehotay DC
    J Mol Cell Cardiol; 1979 Jun; 11(6):591-9. PubMed ID: 37344
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective inhibition of rat and human cardiac guanylate cyclase by doxorubicin (adriamycin): possible link to anthracycline cardiotoxicity.
    Levey GS; Levey BA; Ruiz E; Lehotay DC
    Trans Assoc Am Physicians; 1979; 92():303-8. PubMed ID: 44927
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs: possible relationship to cardiotoxicity.
    Lehotay DC; Levey BA; Rogerson BJ; Levey GS
    Cancer Treat Rep; 1982 Feb; 66(2):311-6. PubMed ID: 6120040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity.
    Levey BA; Ruiz E; Rogerson B; Lehotay DC; Levey GS
    Cancer Treat Rep; 1980; 64(10-11):1127-8. PubMed ID: 6109566
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of cardiac guanylate cyclase by doxorubicin and some of its analogs.
    Lehotay DC; Levey BA; Levey GS
    Biomed Pharmacother; 1983; 37(7):312-6. PubMed ID: 6141818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of vivo doxorubicin (adriamycin) and aclacinomycin administration on guanylate cyclase activity in rat tissue.
    Lehotay DC; Levey BA; Rogerson BJ; Levey GS
    Proc Soc Exp Biol Med; 1981 Sep; 167(4):459-62. PubMed ID: 6116236
    [No Abstract]   [Full Text] [Related]  

  • 7. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin.
    Gewirtz DA
    Biochem Pharmacol; 1999 Apr; 57(7):727-41. PubMed ID: 10075079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between effects of anthracyclines on in vitro cardiac guanyl cyclase and in vivo cardiotoxicity.
    Zbinden G
    Cancer Treat Rep; 1982 Aug; 66(8):1677-8. PubMed ID: 6125261
    [No Abstract]   [Full Text] [Related]  

  • 9. Alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.
    Taatjes DJ; Gaudiano G; Resing K; Koch TH
    J Med Chem; 1996 Oct; 39(21):4135-8. PubMed ID: 8863788
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of coenzyme Q10-enzymes, succinoxidase and NADH-oxidase, by adriamycin and other quinones having antitumor activity.
    Iwamoto Y; Hansen IL; Porter TH; Folkers K
    Biochem Biophys Res Commun; 1974 Jun; 58(3):633-8. PubMed ID: 4152017
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective inhibition of cardiac cyclic nucleotide phosphodiesterases by doxorubicin and daunorubicin.
    Law J; Fumagalli A; Schein PS; Rahman A
    Life Sci; 1985 Feb; 36(6):589-99. PubMed ID: 2982070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone.
    Zijlstra JG; Meijer C; Timmer-Bosscha H; Le TK; de Vries EG; Mulder NH
    Eur J Respir Dis Suppl; 1987; 149():53-5. PubMed ID: 3034649
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple interference of anthracyclines with mitochondrial creatine kinases: preferential damage of the cardiac isoenzyme and its implications for drug cardiotoxicity.
    Tokarska-Schlattner M; Wallimann T; Schlattner U
    Mol Pharmacol; 2002 Mar; 61(3):516-23. PubMed ID: 11854431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implications.
    Mordente A; Minotti G; Martorana GE; Silvestrini A; Giardina B; Meucci E
    Biochem Pharmacol; 2003 Sep; 66(6):989-98. PubMed ID: 12963485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of anthracycline antibiotics on the reconstituted mitochondrial tricarboxylate carrier.
    Stipani I; Capalbo MI; Zara V
    Biochem Biophys Res Commun; 1989 Nov; 164(3):1281-7. PubMed ID: 2590202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance.
    Hintzpeter J; Seliger JM; Hofman J; Martin HJ; Wsol V; Maser E
    Toxicol Appl Pharmacol; 2016 Feb; 293():21-9. PubMed ID: 26773812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthracyclines selectively decrease alpha cardiac actin mRNA abundance in the rat heart.
    Papoian T; Lewis W
    Am J Pathol; 1992 Nov; 141(5):1187-95. PubMed ID: 1443052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute doxorubicin (adriamycin) dosage does not reduce cardiac protein synthesis in vivo, but decreases diaminopeptidase I and proline endopeptidase activities.
    Zima T; Tesar V; Mantle D; Koll M; Patel V; Richardson PJ; Preedy VR
    Exp Mol Pathol; 2001 Apr; 70(2):154-61. PubMed ID: 11263958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anthracycline antitumor agents doxorubicin and daunorubicin reduce the activity of Candida albicans phospholipase B.
    Arai R; Sugita T; Nishikawa A
    Microbiol Immunol; 2004; 48(9):665-7. PubMed ID: 15383703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.